| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A note on masking in the SOX trial
|
Berger, Vance W
|
|
2015
|
12 |
2 |
p. 177-177
|
artikel
|
| 2 |
Are outcome-adaptive allocation trials ethical?
|
Hey, Spencer Phillips
|
|
2015
|
12 |
2 |
p. 102-106
|
artikel
|
| 3 |
Automated measurements for individualized heart rate correction of the QT interval
|
Mason, Jay W
|
|
2015
|
12 |
2 |
p. 149-155
|
artikel
|
| 4 |
Clinician-trialist rounds: 26. Sabbaticals. Part 1: Should I take a sabbatical?
|
Straus, Sharon E
|
|
2015
|
12 |
2 |
p. 174-176
|
artikel
|
| 5 |
Commentary on Hey and Kimmelman
|
Joffe, Steven
|
|
2015
|
12 |
2 |
p. 116-118
|
artikel
|
| 6 |
Commentary on Hey and Kimmelman
|
Korn, Edward L
|
|
2015
|
12 |
2 |
p. 122-124
|
artikel
|
| 7 |
Commentary on Hey and Kimmelman
|
Lee, J Jack
|
|
2015
|
12 |
2 |
p. 110-112
|
artikel
|
| 8 |
Commentary on Hey and Kimmelman
|
Buyse, Marc
|
|
2015
|
12 |
2 |
p. 119-121
|
artikel
|
| 9 |
Commentary on Hey and Kimmelman
|
Berry, Donald A
|
|
2015
|
12 |
2 |
p. 107-109
|
artikel
|
| 10 |
Commentary on Hey and Kimmelman
|
Saxman, Scott Brian
|
|
2015
|
12 |
2 |
p. 113-115
|
artikel
|
| 11 |
E-health data to support and enhance randomised controlled trials in the United Kingdom
|
Harron, Katie
|
|
2015
|
12 |
2 |
p. 180-182
|
artikel
|
| 12 |
Ethical concerns about adaptive randomization
|
Begg, Colin B
|
|
2015
|
12 |
2 |
p. 101-101
|
artikel
|
| 13 |
Food and Drug Administration guidance on progression-free survival and the intention-to-treat principle
|
Dixon, Dennis
|
|
2015
|
12 |
2 |
p. 179-179
|
artikel
|
| 14 |
Marvin Zelen, 1927–2014
|
Gelber, Richard D
|
|
2015
|
12 |
2 |
p. 183-184
|
artikel
|
| 15 |
Missing not at random models for masked clinical trials with dropouts
|
Kang, Shan
|
|
2015
|
12 |
2 |
p. 139-148
|
artikel
|
| 16 |
Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: The Breastfeeding, Antiretrovirals and Nutrition study experience
|
Sellers, Christopher J
|
|
2015
|
12 |
2 |
p. 156-165
|
artikel
|
| 17 |
Rejoinder
|
Hey, Spencer Phillips
|
|
2015
|
12 |
2 |
p. 125-127
|
artikel
|
| 18 |
Response
|
Kahn, Susan R
|
|
2015
|
12 |
2 |
p. 178-178
|
artikel
|
| 19 |
Suspension of accrual in phase II cancer clinical trials
|
Li, Yimei
|
|
2015
|
12 |
2 |
p. 128-138
|
artikel
|
| 20 |
The impact of registration of clinical trials units: The UK experience
|
McFadden, Eleanor
|
|
2015
|
12 |
2 |
p. 166-173
|
artikel
|
Tijdschrift beschrijving